SCHEMBL30156809

SCHEMBL30156809

O=C(c1c(O)cc(O)cc1OCc1ccccc1)N1Cc2cccc(Br)c2C1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRAP1 Q12931 4/20 0.51
HSP90B1 P14625 2/20 0.42
ABHD6 Q9BV23 1/20 0.41
HSP90AA1 P07900 3/20 0.40
ALDH1A1 P00352 2/20 0.40
MAPT P10636 2/20 0.40
HPGD P15428 1/20 0.40
ATM Q13315 1/20 0.40
SPR P35270 1/20 0.40
MEN1 O00255 1/20 0.39
NPC1 O15118 1/20 0.39
LMNA P02545 1/20 0.39
GAA P10253 1/20 0.39
STAT3 P40763 1/20 0.39
STAT1 P42224 1/20 0.39
RAB9A P51151 1/20 0.39
KMT2A Q03164 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HSP90AB1 P08238 1/20 0.39
SLC5A1 P13866 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24913881 1.00 TRAP1 (0.51) TRAP1HSP90B1ABHD6HSP90AA1ALDH1A1
SCHEMBL30368420 0.89 SPR (0.49) TRAP1HSP90B1HSP90AA1MAPTSPR
SCHEMBL25668954 0.89 SPR (0.49) TRAP1HSP90B1HSP90AA1MAPTSPR
SCHEMBL30156653 0.89 TRAP1 (0.41) TRAP1HSP90B1HSP90AA1SPRHSP90AB1
SCHEMBL24913845 0.89 TRAP1 (0.41) TRAP1HSP90B1HSP90AA1SPRHSP90AB1
SCHEMBL30368285 0.88 TRAP1 (0.54) TRAP1HSP90B1ABHD6ALDH1A1MEN1
SCHEMBL25668982 0.88 TRAP1 (0.54) TRAP1HSP90B1ABHD6ALDH1A1MEN1
SCHEMBL24913883 0.87 SLC6A9 (0.40) TRAP1HSP90B1HSP90AA1ALDH1A1SPR
SCHEMBL24913931 0.87 TRAP1 (0.40) TRAP1HSP90B1HSP90AA1SPRHSP90AB1
SCHEMBL30156544 0.87 TRAP1 (0.40) TRAP1HSP90B1HSP90AA1SPRHSP90AB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240293392-A1 INHIBITOR COMPOUNDS Neophore Limited (GB) 2024-09-05 US disclosed
CN-117693507-A Inhibitor compounds 奈奥芬莱有限公司 2024-03-12 CN disclosed
WO-2023002165-A1 INHIBITOR COMPOUNDS Neophore Limited (GB) 2023-01-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240293392-A1 INHIBITOR COMPOUNDS MSH2, PMS2, MSH6 TRAP1 1853/4885HSP90B1 1422/4885ABHD6 4782/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.